James Christensen
Director/Board Member chez BOUNDLESS BIO, INC.
Fortune : - $ au 31/03/2024
Profil
Actuellement, James G. Christensen occupe le poste de Chief Scientific Officer & Executive VP chez Mirati Therapeutics, Inc. Il est également membre du conseil d'administration de BCTG Acquisition Corp. Auparavant, il était directeur principal de la médecine de précision en oncologie chez Pfizer Inc. Le Dr Christensen a obtenu un doctorat de l'université d'État de Caroline du Nord.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de James Christensen
| Sociétés | Poste | Début |
|---|---|---|
| BOUNDLESS BIO, INC. | Director/Board Member | 02/10/2023 |
Anciens postes connus de James Christensen
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 23/01/2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2013 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | - |
Formation de James Christensen
| North Carolina State University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
| Boundless Bio, Inc. | |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance BCTG Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in May 2020 and is headquartered in San Diego, CA. | Finance |
